Leukoencephalopathy clinical trials

Explore recruiting leukoencephalopathy clinical trials.

Recruiting leukoencephalopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Leukoencephalopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP)

Germany, Netherlands, France

Phase II and Phase III (Integrated) EU CTIS Study details

Pembrolizumab in progressive multifocal leukoencephalopathy (PML) in immunocompromised patients without HIV infection (PENALTY)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric Patients With Ulcerative Colitis or Crohn's Disease

Greece, Poland, Belgium, Croatia, Italy, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

CERICA - CERebrolysin In CADASIL - A randomized, double-blind, single-centre, two-period cross-over, placebo-controlled trial on safety and efficacy in patients with genetically proven CADASIL

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized Trial of the I-BFM-SG for the Management of Childhood non-mature-B Acute Lymphoblastic Leukemia

Greece, Hungary, Croatia, Slovenia

Therapeutic use (Phase IV) EU CTIS Study details

CHARACTERIZATION OF ASTROCYTE REACTIVITY WITH [18F]F-DED PET IN NEURODEGENERATIVE DISEASES

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Leukoencephalopathy trials by city

Leukoencephalopathy in Toronto Leukoencephalopathy in Vancouver Leukoencephalopathy in Montreal Leukoencephalopathy in Calgary Leukoencephalopathy in Edmonton Leukoencephalopathy in Ottawa Leukoencephalopathy in Winnipeg Leukoencephalopathy in Quebec City Leukoencephalopathy in Hamilton Leukoencephalopathy in Kitchener Leukoencephalopathy in London Leukoencephalopathy in Halifax Leukoencephalopathy in New York Leukoencephalopathy in Los Angeles Leukoencephalopathy in Chicago Leukoencephalopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease